In one paragraphArticle in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Feria HasanpourInstitute of Pharmaceutical Technology and Regulatory Affairs, Faculty of Pharmacy, University of Szeged, 6 Eötvös Str., H-6720 Szeged, Hungary.ORCID 0009-0007-5592-8147 Oliwia KordylChair and Department of Pharmaceutical Technology, 3D Printing Division, Poznan University of Medical Sciences, 3 Rokietnicka Str., 60-806 Poznań, Poland.
Zuzanna StyrnaStudent's Research Group of Pharmaceutical Technology, The Student Scientific Society of Poznan University of Medical Sciences, 5 Rokietnicka Str., 60-806 Poznań, Poland.
Barbara JadachChair and Department of Pharmaceutical Technology, 3D Printing Division, Poznan University of Medical Sciences, 3 Rokietnicka Str., 60-806 Poznań, Poland.ORCID 0000-0001-5222-4557 Tomasz OsmałekChair and Department of Pharmaceutical Technology, 3D Printing Division, Poznan University of Medical Sciences, 3 Rokietnicka Str., 60-806 Poznań, Poland.ORCID 0000-0002-6939-2888 Ferhan AyaydinFunctional Cell Biology and Immunology Advanced Core Facility (FCBI), Hungarian Centre of Excellence for Molecular Medicine (HCEMM), University of Szeged, 6 Korányi Ave., H-6720 Szeged, Hungary.ORCID 0000-0002-9126-0865 Mária Budai-SzűcsInstitute of Pharmaceutical Technology and Regulatory Affairs, Faculty of Pharmacy, University of Szeged, 6 Eötvös Str., H-6720 Szeged, Hungary.ORCID 0000-0001-5187-5702 Anita KovácsInstitute of Pharmaceutical Technology and Regulatory Affairs, Faculty of Pharmacy, University of Szeged, 6 Eötvös Str., H-6720 Szeged, Hungary.ORCID 0000-0001-5593-1329 Szilvia BerkóInstitute of Pharmaceutical Technology and Regulatory Affairs, Faculty of Pharmacy, University of Szeged, 6 Eötvös Str., H-6720 Szeged, Hungary.ORCID 0000-0002-3842-8876 Funding
Ministry of Culture and Innovation of Hungary from the National Research, Development and Innovation Fund TKP2021-EGA-32Ministry of Culture and Innovation's University Research Scholarship Program, financed from the National Research, Development, and Innovation Fund EKÖP-201-SZTEOpen Access Fund of the University of Szeged 8467
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
3D printingadditive manufacturingconical and pyramidal geometrydermal deliveryhydrogel coatinglidocainemicroneedle arrays
Identifiers
PMID42198212
PMCPMC13210547
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390